XRAY vs. NVST, SDC, WST, ALGN, COO, MMSI, HAE, NEOG, QDEL, and ICUI
Should you be buying DENTSPLY SIRONA stock or one of its competitors? The main competitors of DENTSPLY SIRONA include Envista (NVST), SmileDirectClub (SDC), West Pharmaceutical Services (WST), Align Technology (ALGN), Cooper Companies (COO), Merit Medical Systems (MMSI), Haemonetics (HAE), Neogen (NEOG), QuidelOrtho (QDEL), and ICU Medical (ICUI). These companies are all part of the "medical" sector.
Envista (NYSE:NVST) and DENTSPLY SIRONA (NASDAQ:XRAY) are both mid-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, valuation, analyst recommendations, community ranking, media sentiment and dividends.
DENTSPLY SIRONA received 428 more outperform votes than Envista when rated by MarketBeat users. Likewise, 61.21% of users gave DENTSPLY SIRONA an outperform vote while only 38.89% of users gave Envista an outperform vote.
In the previous week, DENTSPLY SIRONA had 2 more articles in the media than Envista. MarketBeat recorded 8 mentions for DENTSPLY SIRONA and 6 mentions for Envista. Envista's average media sentiment score of 1.59 beat DENTSPLY SIRONA's score of 0.97 indicating that DENTSPLY SIRONA is being referred to more favorably in the news media.
Envista currently has a consensus price target of $25.86, suggesting a potential upside of 41.72%. DENTSPLY SIRONA has a consensus price target of $35.22, suggesting a potential upside of 27.20%. Given DENTSPLY SIRONA's higher probable upside, equities analysts clearly believe Envista is more favorable than DENTSPLY SIRONA.
Envista has higher earnings, but lower revenue than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.
Envista has a beta of 1.34, indicating that its share price is 34% more volatile than the S&P 500. Comparatively, DENTSPLY SIRONA has a beta of 1.04, indicating that its share price is 4% more volatile than the S&P 500.
95.7% of DENTSPLY SIRONA shares are held by institutional investors. 1.3% of Envista shares are held by company insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
DENTSPLY SIRONA has a net margin of -2.41% compared to DENTSPLY SIRONA's net margin of -4.70%. Envista's return on equity of 11.54% beat DENTSPLY SIRONA's return on equity.
Summary
DENTSPLY SIRONA beats Envista on 13 of the 18 factors compared between the two stocks.
Get DENTSPLY SIRONA News Delivered to You Automatically
Sign up to receive the latest news and ratings for XRAY and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding XRAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
DENTSPLY SIRONA Competitors List
Related Companies and Tools
